Home > Financial Ratios > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
EV/Core EBITDA

    Back to All Ratios
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 31.0919.4831.1331.3232.67

What is the latest EV/Core EBITDA ratio of MEDICAMEN BIOTECH ?

The latest EV/Core EBITDA ratio of MEDICAMEN BIOTECH is 31.09 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202531.09
Mar202419.48
Mar202331.13
Mar202231.32
Mar202132.67

How is EV/Core EBITDA of MEDICAMEN BIOTECH Trending?

Years EV/Core EBITDA % Change
Mar2025 31.09
59.60
Mar2024 19.48
-37.42
Mar2023 31.13
-0.61
Mar2022 31.32
-4.13
Mar2021 32.67 -

Other Financial Ratios of MEDICAMEN BIOTECH


Compare EV/Core EBITDA ratio of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹403.9 Cr -5.4% -3.3% 2.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹424,466.0 Cr -0.8% -5.1% 6.3% Stock Analytics
DIVIS LABORATORIES ₹246,222.0 Cr -3.2% -1.4% 53.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,300.0 Cr -1.6% -6% 32.1% Stock Analytics
CIPLA ₹107,447.0 Cr 0% -3.6% -13.2% Stock Analytics
DR REDDYS LABORATORIES ₹103,471.0 Cr 3.1% 8.7% -1.5% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

-5.4%

-3.3%

2.6%

SENSEX

-0.1%

-2.3%

-10.7%


You may also like the below Video Courses